Skip to main content

Table 2 Major therapeutic characteristics of ICCU admission

From: Association of fine particulate matter exposure with acute noncardiovascular critical illnesses and in-hospital outcomes in patients receiving intensive cardiac care

 

The 2-day average concentration of PM2.5 before ICCU admission

 

Characteristic

≤36 μg/m3

37-63 μg/m3

≥64 μg/m3

P value

(N = 804)

(N = 773)

(N = 760)

Percutaneous coronary intervention

446(55.5)

462(59.8)

433(57.0)

0.531

Temporary pacemaker

78(9.7)

72(9.3)

60(7.9)

0.214

Conventional pacemaker

46(5.7)

41(5.3)

24(3.2)

0.018

ICD

7(0.9)

4(0.5)

4(0.5)

0.389

CRT-P/D

3(0.4)

5(0.6)

3(0.4)

0.939

Ablation for tachycardia

43(5.3)

20(2.6)

25(3.3)

0.030

LAA closure

16(2.0)

2(0.3)

13(1.7)

0.593

TAVI or BAV

18(2.2)

10(1.3)

23(3.0)

0.302

Interventional therapy for CHD

6(0.7)

8(1.0)

5(0.7)

0.856

Intra-aortic balloon pump

28(3.5)

32(4.1)

27(3.6)

0.932

Inotropes or vasopressors

90(11.2)

115(14.9)

107(14.1)

0.089

Arterial line

111(13.8)

128(16.6)

168(22.1)

< 0.001

Central venous catheter

66(8.2)

74(9.6)

87(11.4)

0.031

Hemodialysis

11(1.4)

20(2.6)

28(3.7)

0.004

Mechanical ventilation

87(10.8)

104(13.5)

125(16.4)

0.001

  1. Data are expressed as counts and percentage
  2. Abbreviation: PM2.5 particulate matter with an aerodynamic diameter less than 2.5 μm, ICD implantable cardioverter defibrillator, CRT-P/D cardiac resynchronization therapy and pacemaker or defibrillator, LAA closure left atrial appendage closure, TAVI transcatheter aortic implantation, BAV balloon aortic valvuloplasty, CHD congenital heart disease